Longfellow Continues to Build Out San Diego Portfolio with First Ground-up Development in Growing Sorrento Mesa Biotech Cluster

Longfellow's groundbreaking at Bioterra follows the firm's rapid expansion last month to two new US markets, Philadelphia, and Maryland-Washington D.C., along the company's first international acquisition in Cambridge, United Kingdom.

"When we first entered the San Diego market in 2018, we had a vision for the future of life science development in the region," said Adam Sichol, Longfellow Real Estate Partners Co-Founder and CEO. "Now four years later that is becoming a reality, as we deliver on large investments across 90 acres in key locations for the regional biotech industry. Bioterra has the distinction of being the first property we're developing from the ground-up, enabling us to build a purpose-built space where our future tenants can thrive. The campus site is an unparalleled location that offers users access to top medical facilities, transit, and amenities."

"We're honored the team at Longfellow trusted McCarthy to lead its first ground-up build for their new Bioterra campus at Sorrento Mesa," said Robert Betz, executive vice president at McCarthy. "McCarthy has a deep well of expertise in the local San Diego life science industry, and we're confident our knowledge in the space-paired with Longfellow's commitment to innovation and sustainability - will deliver an unforgettable campus."

Longfellow currently has a total investment and development portfolio of approximately 15 million square feet and over $10bn in total asset value, with large footprints in the nation's most dynamic centers for the biotech industry including San Diego, Boston, San Francisco, and the Research Triangle.

###

About Longfellow Real Estate Partners

Longfellow Real Estate Partners is the largest private life science real estate services firm in the United States. The firm's portfolio spans approximately 15 million square feet of laboratory and technology space, concentrated in the nation's top markets for bio-innovation on both coasts including Boston-Cambridge, Maryland-Washington D.C., New York City, Philadelphia, San Diego, San Francisco Bay Area, the Research Triangle of North Carolina, along with the firm's expansion to the United Kingdom. Longfellow acquires and develops facilities in strategic locations and builds long-term relationships with research-centric organizations including life science companies, universities, medical centers, and research institutes. The firm's institutional capabilities and entrepreneurial vision enables Longfellow to deliver high-quality laboratories and innovation space while satisfying each customer's unique requirements.

For more information visit lfrep.com.